Missing/wrong data?
Log in to edit
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
scientific article published on 16 February 2017
Author/s
author: Evandro de Azambuja, Josep Baselga, Luca Gianni, Michael Untch, Mitch Dowsett, Aron Goldhirsch, Marion Procter, Herceptin Adjuvant (HERA) Trial Study Team, Christian Jackisch
Work details
Publication date
February 17, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.